Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor
  2. Schmidt, Karyn; Weidmann, Chase A; Hilimire, Thomas A; Yee, Elaine; Hatfield, Breanne M; Schneekloth,Jay; Weeks, Kevin M; Novina, Carl D
  3. Cell reports. 2020, Jan 14; 30(2): 541-554.e5.
  1. 2.   Conformational Control of the Binding of the Transactivation Domain of the MLL Protein and c-Myb to the KIX Domain of CREB
  2. Korkmaz, E. N.; Nussinov, R.; Haliloglu, Y.
  3. Plos Computational Biology. 2012, Mar; 8(3):
  1. 3.   SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
  2. Ponugoti, B.; Kim, D. H.; Xiao, Z.; Smith, Z.; Miao, J.; Zang, M. W.; Wu, S. Y.; Chiang, C. M.; Veenstra, T. D.; Kemper, J. K.
  3. Journal of Biological Chemistry. 2010, Oct; 285(44): 33959-33970.
  1. 4.   An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
  2. Kessl, J. J.; Eidahl, J. O.; Shkriabai, N.; Zhao, Z. J.; Mckee, C. J.; Hess, S.; Burke, T. R.; Kvaratskhelia, M.
  3. Molecular Pharmacology. 2009 76(4): 824-832.
  1. 5.   Cited1 and cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis
  2. Boyle, S.; Shioda, T.; Perantoni, A. O.; de Caestecker, M.
  3. Developmental Dynamics. 2007, Aug; 236(8): 2321-2330.
  1. 6.   PTIP associates with MLL3-and MLL4-containing histone H3 lysine 4 methyltransferase complex
  2. Cho, Y. W.; Hong, T.; Hong, S.; Guo, H.; Yu, H.; Kim, D.; Guszczynski, T.; Dressler, G. R.; Copeland, T. D.; Kalkum, M.; Ge, K.
  3. Journal of Biological Chemistry. 2007, Jul; 282(28): 20395-20406.
  1. 7.   E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells
  2. Mani, A.; Oh, A. S.; Bowden, E. T.; Lahusen, T.; Lorick, K. L.; Weissman, A. M.; Schlegel, R.; Wellstein, A.; Riegel, A. T.
  3. Cancer Research. 2006, Sep; 66(17): 8680-8686.
  1. 8.   Coactivators and corepressors of NF-kappa B in I kappa Beta alpha gene promoter
  2. Gao, Z. G.; Chiao, P.; Zhang, X.; Zhang, X. H.; Lazar, M. A.; Seto, E.; Young, H. A.; Ye, J. P.
  3. Journal of Biological Chemistry. 2005, JUN 3; 280(22): 21091-21098.
  1. 9.   Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid- responsive promoters by binding directly to p300/CBP coactivators
  2. Kino, T.; Gragerov, A.; Slobodskaya, O.; Tsopanomichalou, M.; Chrousos, G. P.; Pavlakis, G. N.
  3. Journal of Virology. 2002 76(19): 9724-9734.
  1. 10.   Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex
  2. Kino, T.; Slobodskaya, O.; Pavlakis, G. N.; Chrousos, G. P.
  3. Journal of Biological Chemistry. 2002 277(4): 2396-2405.
  1. 11.   Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBP beta) - Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBP beta
  2. Guo, S. D.; Cichy, S. B.; He, X. W.; Yang, Q. Y.; Ragl, M.; Ghosh, A. K.; Johnson, P. F.; Unterman, T. G.
  3. Journal of Biological Chemistry. 2001 276(11): 8516-8523.
  1. 12.   Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER)
  2. Bodor, J.; Feigenbaum, L.; Bodorova, J.; Bare, C.; Reitz, M. S.; Gress, R. E.
  3. Journal of Leukocyte Biology. 2001 69(6): 1053-1059.
  1. 13.   Acetyltransferases and tumour suppression
  2. Phillips, A. C.; Vousden, K. H.
  3. Breast Cancer Research. 2000 2(4): 244-246.
  1. 14.   The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor
  2. Kino, T.; Gragerov, A.; Kopp, J. B.; Stauber, R. H.; Pavlakis, G. N.; Chrousos, G. P.
  3. Journal of Experimental Medicine. 1999 189(1): 51-61.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel